TP53 and cancer: Previously, mutant p53 protein that accumulated in cancer cells was reported to be immunogenic and to lead to the generation of p53-Ab in vitro.12,13,14 These results suggest the possibility that patient immune systems may recognize the abnormally expressed p53 protein as a cancer-specific antigen.